Rankings
▼
Calendar
BBIO Q1 2025 Earnings — BridgeBio Pharma, Inc. Revenue & Financial Results | Market Cap Arena
BBIO
BridgeBio Pharma, Inc.
$14B
Q1 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$117M
-44.8% YoY
Gross Profit
$114M
97.7% margin
Operating Income
-$104M
-89.5% margin
Net Income
-$167M
-143.5% margin
EPS (Diluted)
$-0.88
QoQ Revenue Growth
+1882.9%
Cash Flow
Operating Cash Flow
-$199M
Free Cash Flow
-$201M
Stock-Based Comp.
$26M
Balance Sheet
Total Assets
$882M
Total Liabilities
$2.5B
Stockholders' Equity
-$1.6B
Cash & Equivalents
$541M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$117M
$211M
-44.8%
Gross Profit
$114M
$211M
-45.9%
Operating Income
-$104M
$343,000
-30529.2%
Net Income
-$167M
-$35M
-375.4%
Revenue Segments
Net Product Revenue
$37M
100%
← FY 2025
All Quarters
Q2 2025 →